
TLO
Unlocking insights from unstructured data.

Accelerating the discovery of life-changing bioactive peptides through AI-driven molecular intelligence.

Nuritas is a pioneering AI biotechnology firm that leverages its proprietary 'Nuri' platform to identify and validate bioactive peptides from natural sources. By 2026, Nuritas has solidified its position as the global leader in the 'Dark Proteome' exploration, using deep learning to predict how specific peptide sequences interact with biological pathways. The technical architecture combines massive proprietary datasets with closed-loop laboratory automation, ensuring that AI predictions are immediately validated through in-vitro and in-vivo testing. Unlike traditional ingredient discovery, which relies on trial and error, the Nuritas Nuri engine utilizes high-resolution proteomics and neural networks to reduce discovery timelines from years to months. The platform focuses on high-impact areas such as muscle health (PeptiStrong), skin rejuvenation (PeptiYouth), and glucose management. For enterprise partners, Nuritas provides a complete R&D pipeline that spans from digital molecular screening to clinical-grade ingredient production, making it a critical infrastructure layer for the next generation of functional foods, supplements, and therapeutic cosmetics.
Nuritas is a pioneering AI biotechnology firm that leverages its proprietary 'Nuri' platform to identify and validate bioactive peptides from natural sources.
Explore all tools that specialize in molecular bioactivity prediction. This domain focus ensures Nuritas delivers optimized results for this specific requirement.
Explore all tools that specialize in discovering novel peptides. This domain focus ensures Nuritas delivers optimized results for this specific requirement.
A deep-learning platform trained on the world's largest proprietary database of bioactive peptides.
Integration of AI predictions with robotic synthesis and testing for real-time model training.
Advanced proteomics used to identify hidden sequences in natural food sources.
Neural networks that simulate human biological responses to specific peptide sequences.
Combines genomic, proteomic, and metabolomic data to refine discovery targets.
Proprietary methods for mass-producing complex peptides at food-grade costs.
A quantitative ranking system for molecular candidates based on potency and safety.
Strategic alignment and therapeutic area definition (e.g., muscle, gut, skin).
Selection of target biological pathways and desired physiological outcomes.
AI-driven screening of the Nuritas proprietary peptide library (Nuri platform).
Predictive modeling of molecular interactions and bioactivity scores.
High-throughput synthesis of the top-ranked peptide candidates.
In-vitro validation within Nuritas' automated laboratory environment.
Data refinement and iteration based on laboratory feedback loops.
Final candidate selection for pilot-scale production.
Clinical protocol design and execution for human efficacy validation.
Regulatory dossier preparation and commercial licensing integration.
All Set
Ready to go
Verified feedback from other users.
"Users praise the platform for its ability to find high-efficacy natural molecules that traditional R&D missed, though the high entry cost limits it to enterprise partners."
Post questions, share tips, and help other users.

Unlocking insights from unstructured data.

A visual data science platform combining visual analytics, data science, and data wrangling.

Open Source OCR Engine capable of recognizing over 100 languages.

AI-enabled precision medicine for data-driven healthcare decisions.

Empowering nonprofits and social businesses with AI-powered solutions.

Enterprise-grade topological data analysis for uncovering hidden patterns in high-dimensional datasets.